New York, New York–(Newsfile Corp. – January 25, 2025) – Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether TransMedics Group (NASDAQ:), Inc. (“TransMedics Group” or the “Company”) (NASDAQ: ™DX) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.
CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION
TransMedics Group operates an organ transplant ecosystem under which it offers patented technology to preserve and mobilize organs, services that support transplant centers and medical teams, and a logistics arm that facilitates the entire chain.
On October 28, 2024, the Company released its 3Q24 financial results. During the associated earnings call, the Company revealed that its revenue missed its estimates by a wide margin and that revenues were down sequentially. On this news, the Company’s stock price fell $39.24, or more than 30%, on October 29, 2024, trading on high trading volume.
Then, after market hours on December 2, 2024, TransMedics Group issued a press release that revealed, among other things, additional information about the Company’s expected growth. Specifically, the Company lowered its FY24 revenue guidance from between $425M and $445M to $428M and $432M. On this news, the Company’s stock fell $13.70, or more than 16%, to close at $71.44 per share on December 3, 2024, trading on unusually high volume.
ARE YOU A POTENTIAL CLASS MEMBER ELIGIBLE TO RECOVER? CLICK HERE
If you purchased or otherwise own TransMedics Group securities and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@scott-scott.com.
CLICK HERE TO FIND OUT IF YOU CAN RECOVER YOUR LOSSES
ABOUT US
Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.
This may be considered Attorney Advertising.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/237019
